WHO ICTRP trial
Efficacy and safety of allogeneic bone marrow transplantation for severe type II…
ChiCTR1800016524 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800016524 |
|---|---|
| Public title | Efficacy and safety of allogeneic bone marrow transplantation for severe type II aplastic anemia |
| Scientific title | The efficacy and safety of allogeneic bone marrow transplantation in the treatment of severe type II aplastic anemia: a multicenter, single arm, prospective study |
| Primary sponsor | Department of Hematology, Second Affiliated Hospital of Dalian Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Treatment study |
| Phase | New Treatment Measure Clinical Study |
| Countries | China |
| Conditions | severe type II aplastic anemia |
| Interventions | Case series:allogeneic bone marrow transplantation |
| Registration date | Jun 6, 2018 |
| Target size | Case series:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: